Subbi Mathur to Insulin-Like Growth Factor II
This is a "connection" page, showing publications Subbi Mathur has written about Insulin-Like Growth Factor II.
Connection Strength
1.208
-
Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected]. Gynecol Oncol. 2005 Sep; 98(3):467-83.
Score: 0.252
-
Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer. Gynecol Oncol. 2003 Dec; 91(3):486-93.
Score: 0.223
-
In vitro downregulation of growth factors by insulin-like growth factor binding protein-3 in cervical cancer. Gynecol Oncol. 2003 Nov; 91(2):410-5.
Score: 0.222
-
Insulin-like growth factor II in gynecological cancers: a preliminary study. Am J Reprod Immunol. 2003 Feb; 49(2):113-9.
Score: 0.211
-
Cervical epidermal growth factor-receptor (EGF-R) and serum insulin-like growth factor II (IGF-II) levels are potential markers for cervical cancer. Am J Reprod Immunol. 2000 Oct; 44(4):222-30.
Score: 0.179
-
Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers. Gynecol Oncol. 2005 Apr; 97(1):206-13.
Score: 0.061
-
Early non-invasive diagnosis of cervical cancer: beyond Pap smears and human papilloma virus (HPV) testing. Cancer Biomark. 2005; 1(2-3):183-91.
Score: 0.060